Apar KishorGantiMD

PubMed

• 7 citations
  Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival.
  Jake Johnson, Whitney Goldner, Duaa Abdallah, Fang Qiu, Apar Kishor Ganti, Anupam Kotwal> ;Journal of the National Comprehensive Cancer Network. 2023 Feb 24
• 3 citations
  Elevated PAF1-RAD52 axis confers chemoresistance to human cancers.
  Sanchita Rauth, Koelina Ganguly, Pranita Atri, Seema Parte, Rama Krishna Nimmakayala, Venkatesh Varadharaj, Palanisamy Nallasamy, Raghupathy Vengoji, Ayoola O Ogunleye...> ;Cell Reports. 2023 Feb 28
• 14 citations
  MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis.
  Parvez Khan, Jawed Akhtar Siddiqui, Prakash G Kshirsagar, Ramakanth Chirravuri Venkata, Shailendra Kumar Maurya, Tamara Mirzapoiazova, Naveenkumar Perumal, Sanjib Chau...> ;Molecular Cancer. 2023 Jan 4
• Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru.
  Marco Galvez-Nino, Rossana Ruiz, Katia Roque, Ofelia Coanqui, Natalia Valdivieso, Mivael Olivera, Apar Kishor Ganti, Luis Mas> ;Thoracic Cancer. 2023 Jan 1
• 4 citations
  Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.
  Imayavaramban Lakshmanan, Saravanakumar Marimuthu, Sanjib Chaudhary, Parthasarathy Seshacharyulu, Satyanarayana Rachagani, Sakthivel Muniyan, Ramakanth Chirravuri-Venk...> ;Oncogene. 2022 Nov 1
• Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small cell lung can...
  Lexie Zidanyue Yang, Qihua He, Jianrong Zhang, Apar Kishor Ganti, Thomas E Stinchcombe, Herbert Pang, Xiaofei Wang> ;Translational Cancer Research. 2022 Oct 1
• 3 citations
  Recurrent Cushing Syndrome From Metastatic Adrenocortical Carcinoma With Fumarate Hydratase Allelic Variant.
  Emily Silverman, Noor Addasi, Muaataz Azzawi, Ernesto Martinez Duarte, Dali Huang, Benjamin Swanson, Apar Kishor Ganti, Gwen Reiser, Abbey L Fingeret, Anupam Kotwal> ;AACE Clinical Case Reports. 2022 Sep 17
• 11 citations
  Novel targeted therapies for advanced non-small lung cancer.
  Omar Abughanimeh, Anahat Kaur, Badi El Osta, Apar Kishor Ganti> ;Seminars in Oncology. 2022 Apr 1
• 2 citations
  Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer.
  Apar Kishor Ganti, Chia-Wei Lin, Erru Yang, William B Wong, Sarika Ogale> ;Journal of Managed Care & Specialty Pharmacy. 2022 Mar 1
• Reply.
  Sanjib Chaudhary, Imayavaramban Lakshmanan, Apar Kishor Ganti, Muzafar A Macha, Surinder K Batra> ;Cancer Letters. 2022 Feb 28
• 2 citations
  Risk of malignancy in patients with chronic kidney disease.
  Ketki K Tendulkar, Brendan Cope, Jianghu Dong, Troy J Plumb, W Scott Campbell, Apar Kishor Ganti> ;Plos One. 2022 Jan 1
• 5 citations
  Senescence marker protein 30 inhibits tumor growth by reducing HDAC4 expression in non-small cell lung cancer.
  Changjian Shao, Kai Guo, Liqun Xu, Yimeng Zhang, Hongtao Duan, Yingtong Feng, Minghong Pan, Di Lu, Xiaoya Ren, Apar Kishor Ganti, Taiki Hakozaki, Jing Han, Xiaolong Ya...> ;Translational Lung Cancer Research. 2021 Dec 1
• 168 citations
  Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.
  Apar Kishor Ganti, Alyssa B Klein, Ion Cotarla, Brian Seal, Engels Chou> ;JAMA Oncology. 2021 Oct 21
• Cisplatin or carboplatin for advanced non-small cell lung cancer: Does it really matter?
  Meghana Kesireddy, Apar Kishor Ganti> ;Translational Lung Cancer Research. 2021 Sep 1
• 2 citations
  Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort
  Bryant R. England, Megan Campany, Harlan Sayles, Punyasha Roul, Yangyuna Yang, Apar Kishor Ganti, Jeremy Sokolove, William H. Robinson, Andreas M. Reimold, Gail S. Ker...> ;International Immunopharmacology. 2021 Apr 29
• 14 citations
  Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring.
  Sanjib Chaudhary, Ramesh Pothuraju, Satyanarayana Rachagani, Jawed A. Siddiqui, Pranita Atri, Kavita Mallya, Mohd W. Nasser, Zafar Sayed, Elizabeth Lyden, Lynette M. S...> ;Cancer Letters. 2021 Jul 10
• 13 citations
  The use of patient-reported outcome measures in phase i oncology clinical trials
  Robert L. Coleman, J. Thaddeus Beck, Joaquina Baranda, Ira Jacobs, Karen E. Smoyer, Lauren J Lee, Zemfira Askerova, J. McGinnis, Apar Kishor Ganti> ;Oncology. 2021 Apr 6
• 14 citations
  ST6GalNAc-I Promotes Lung Cancer Metastasis by Altering MUC5AC Sialylation
  Imayavaramban Lakshmanan, Sanjib Chaudhary, Raghupathy Vengoji, Parthasarathy Seshacharyulu, Satyanarayana Rachagani, Joseph Carmicheal, Rahat Jahan, Pranita Atri, Ram...> ;Molecular Oncology. 2021 Jul 1
• 41 citations
  RNA-based therapies: A cog in the wheel of lung cancer defense.
  Parvez Khan, Jawed A. Siddiqui, Imayavaramban Lakshmanan, Apar Kishor Ganti, Ravi Salgia, Maneesh Jain, Surinder K. Batra, Mohd W. Nasser> ;Molecular Cancer. 2021 Mar 19
• 1 citations
  Factors Associated With Treatment Refusal and Impact of Treatment Refusal on Survival of Patients With Small Cell Lung Cancer.
  Poppy Elvira Deviany, Apar Kishor Ganti, K M Monirul Islam> ;Oncology. 2021 Mar 15
• 6 citations
  Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer
  Emily Keit, Brendan G Coutu, Weining Zhen, Chi Zhang, Chi Lin, Nathan R. Bennion, Apar Kishor Ganti, Vinicius Ernani, Michael J. Baine> ;Annals of Translational Medicine. 2021 Feb 1
• 28 citations
  Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease.
  Parvez Khan, Jawed A. Siddiqui, Shailendra Kumar Maurya, Imayavaramban Lakshmanan, Maneesh Jain, Apar Kishor Ganti, Ravi Salgia, Surinder K. Batra, Mohd W. Nasser> ;Seminars in Cancer Biology. 2020 Nov 18
• 9 citations
  Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer.
  Sanjib Chaudhary, Vi Dam, Koelina Ganguly, Sunandini Sharma, Pranita Atri, Ramakanth Chirravuri-Venkata, Jesse L. Cox, Zafar Sayed, Dwight T. Jones, Apar Kishor Ganti,...> ;Cancer Letters. 2020 Nov 1
• The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adj...
  Vinicius Ernani, Adams Kusi Appiah, Michael J. Baine, Lynette M. Smith, Apar Kishor Ganti> ;Cancer Treatment and Research Communications. 2020 Jul 21
• Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
  Amulya Yellala, Apar Kishor Ganti> ;Translational Lung Cancer Research. 2020 Apr 13
• Join now to see all